| 0 |
ANION GAP ABNORMAL |
4 |
0.0149 |
| 1 |
ANION GAP |
5 |
0.0079 |
| 2 |
CENTRAL NERVOUS SYSTEM STIMULATION |
1 |
0.0056 |
| 3 |
HOMELESS |
2 |
0.0045 |
| 4 |
SUBSTANCE ABUSER |
1 |
0.0044 |
| 5 |
HYPERREFLEXIA |
7 |
0.0020 |
| 6 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
0.0017 |
| 7 |
CEREBRAL VASOCONSTRICTION |
1 |
0.0014 |
| 8 |
AMPHETAMINES POSITIVE |
1 |
0.0013 |
| 9 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
0.0008 |
| 10 |
RESPIRATORY DEPRESSION |
9 |
0.0007 |
| 11 |
SUBSTANCE USE |
1 |
0.0006 |
| 12 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 13 |
EUPHORIC MOOD |
5 |
0.0005 |
| 14 |
LIPODYSTROPHY ACQUIRED |
1 |
0.0005 |
| 15 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
1 |
0.0004 |
| 16 |
ALCOHOL ABUSE |
1 |
0.0004 |
| 17 |
PNEUMONIA ASPIRATION |
9 |
0.0004 |
| 18 |
FAMILY STRESS |
1 |
0.0003 |
| 19 |
METABOLIC ACIDOSIS |
9 |
0.0003 |
| 20 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 21 |
SELF-MEDICATION |
1 |
0.0002 |
| 22 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
8 |
0.0002 |
| 23 |
NYSTAGMUS |
1 |
0.0002 |
| 24 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 25 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 26 |
DRUG ABUSER |
1 |
0.0002 |
| 27 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 28 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 29 |
COMA |
7 |
0.0001 |
| 30 |
DRUG ABUSE |
11 |
0.0001 |
| 31 |
DISSOCIATION |
1 |
0.0001 |
| 32 |
DELUSION |
2 |
0.0001 |
| 33 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 34 |
PARANOIA |
2 |
0.0001 |
| 35 |
CARDIOTOXICITY |
1 |
0.0001 |
| 36 |
LEUKAEMIA |
1 |
0.0001 |
| 37 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 38 |
TACHYCARDIA |
9 |
0.0001 |
| 39 |
BRAIN INJURY |
1 |
0.0001 |
| 40 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 41 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 42 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 43 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 44 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 45 |
DRUG DEPENDENCE |
11 |
0.0001 |
| 46 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 47 |
ACUTE KIDNEY INJURY |
10 |
0.0001 |
| 48 |
MANIA |
1 |
0.0001 |
| 49 |
TOXICITY TO VARIOUS AGENTS |
10 |
0.0001 |
| 50 |
NEUROTOXICITY |
1 |
0.0001 |
| 51 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 52 |
TREMOR |
8 |
0.0000 |
| 53 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 54 |
TOOTH DISORDER |
1 |
0.0000 |
| 55 |
HYPOTENSION |
9 |
0.0000 |
| 56 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 57 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 58 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 59 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 60 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 61 |
RASH MACULAR |
1 |
0.0000 |
| 62 |
RESTLESSNESS |
1 |
0.0000 |
| 63 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 64 |
DYSARTHRIA |
1 |
0.0000 |
| 65 |
HALLUCINATION |
2 |
0.0000 |
| 66 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 67 |
DYSKINESIA |
1 |
0.0000 |
| 68 |
CARDIAC ARREST |
2 |
0.0000 |
| 69 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 70 |
MENTAL DISORDER |
1 |
0.0000 |
| 71 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 72 |
HEART RATE INCREASED |
2 |
0.0000 |
| 73 |
AGGRESSION |
1 |
0.0000 |
| 74 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 75 |
NERVOUSNESS |
1 |
0.0000 |
| 76 |
SPEECH DISORDER |
1 |
0.0000 |
| 77 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 78 |
DEPENDENCE |
1 |
0.0000 |
| 79 |
MEDICATION ERROR |
1 |
0.0000 |
| 80 |
HERPES ZOSTER |
1 |
0.0000 |
| 81 |
LETHARGY |
1 |
0.0000 |
| 82 |
SEIZURE |
2 |
0.0000 |
| 83 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 84 |
UNDERDOSE |
1 |
0.0000 |
| 85 |
AGITATION |
1 |
0.0000 |
| 86 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 87 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 88 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 89 |
FEELING ABNORMAL |
3 |
0.0000 |
| 90 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 91 |
DYSPHAGIA |
1 |
0.0000 |
| 92 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 93 |
CONTUSION |
1 |
0.0000 |
| 94 |
SYNCOPE |
1 |
0.0000 |
| 95 |
ERYTHEMA |
2 |
0.0000 |
| 96 |
SEPSIS |
1 |
0.0000 |
| 97 |
WEIGHT INCREASED |
2 |
0.0000 |
| 98 |
PALPITATIONS |
1 |
0.0000 |
| 99 |
JOINT SWELLING |
1 |
0.0000 |
| 100 |
HYPERHIDROSIS |
1 |
0.0000 |
| 101 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 102 |
DRUG INTERACTION |
1 |
0.0000 |
| 103 |
PNEUMONIA |
2 |
0.0000 |
| 104 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 105 |
DIZZINESS |
3 |
0.0000 |
| 106 |
CHEST PAIN |
1 |
0.0000 |
| 107 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 108 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 109 |
ALOPECIA |
1 |
0.0000 |
| 110 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 111 |
HYPERTENSION |
1 |
0.0000 |
| 112 |
CONSTIPATION |
1 |
0.0000 |
| 113 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 114 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 115 |
FATIGUE |
3 |
0.0000 |
| 116 |
ANXIETY |
1 |
0.0000 |
| 117 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 118 |
DEATH |
2 |
0.0000 |
| 119 |
OFF LABEL USE |
2 |
0.0000 |
| 120 |
DRUG INEFFECTIVE |
1 |
0.0000 |